QSAR Study on 5-Lipoxygenase Activating Protein (FLAP) Inhibitors: The Derivatives of 2,2-Bisaryl-Bicycloheptane

被引:0
|
作者
Sharma, Brij Kishore [1 ]
Pilania, Pradeep [1 ]
Singh, Prithvi [1 ]
机构
[1] SK Govt Coll, Dept Chem, Sikar 332001, India
关键词
2,2-bisaryl-bicycloheptane derivatives; 5-lipoxygenase activating protein (FLAP) inhibitors; Combinatorial protocol in multiple linear regression (CP-MLR); Partial least square (PLS) analysis; LEUKOTRIENE BIOSYNTHESIS INHIBITORS; VARIABLE SELECTION; SUBSTITUTED 2,2-BISARYL-BICYCLOHEPTANES; POTENT; INDOLES; DISEASE; MODELS; ACID;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The FLAP inhibitory activity of 2,2-bisaryl-bicycloheptane derivatives has been quantitatively analyzed in terms of Dragon descriptors. The derived QSAR models have provided rationales to explain the FLAP inhibitory activity of 2,2-bisaryl-bicycloheptane derivatives. The presence of quinolinylmethoxy substituent at R(2)-position in a molecular structure is a crucial feature for the FLAP inhibitory activity. The occurrence of R-CR-X type structural fragment (descriptor C-028) and higher number of sulfur atoms (descriptor nS) in a molecular structure are prevalent to rationalize the FLAP actions of bicycloheptane derivatives. The topological charge indices (descriptors GGI3, 3(rd) order Galvez topological charge index; and JGI4, 4(th) order Galvez mean topological charge index), path/walk ratio 2 (Randic's molecular shape descriptor PW2) and atomic polarizabilities at lag 2 (descriptor GATS2p, Geary autocorrelation of lag 2 weighted by atomic polarizabilities) are also important to explain the FLAP activity. The PLS analysis has also confirmed the dominance of information content of CP-MLR identified descriptors. Applicability domain analysis revealed that the suggested model matches the high quality parameters with good fitting power and the capability of assessing external data, and all of the compounds were within the applicability domain of the proposed models and were evaluated correctly.
引用
收藏
页码:32 / 43
页数:12
相关论文
共 50 条
  • [31] Synthesis of [3H] and [2H6]AZD6642, an inhibitor of 5-lipoxygenase activating protein (FLAP)
    Lindelof, Asa
    Ericsson, Cecilia
    Simonsson, Roger
    Nilsson, Goran
    Gronberg, Gunnar
    Elmore, Charles S.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2016, 59 (09): : 340 - 345
  • [32] What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases
    Evans, Jilly F.
    Ferguson, Andrew D.
    Mosley, Ralph T.
    Hutchinson, John H.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2008, 29 (02) : 72 - 78
  • [33] Discovery and synthesis of tetrasubstituted aryl aminopyrazines as potent 5-lipoxygenase-activating protein (FLAP) inhibitors
    Meduna, Steven P.
    Blevitt, Jonathan M.
    Chang, Leon
    Coe, Kevin J.
    Crawford, Shelby
    de Leon-Tabaldo, Aimee
    DiSepio, Daniel
    Eccles, Wendy
    Everson, Anita M.
    Feinstein, Mark A.
    Fitzgerald, Anne E.
    Hack, Michael D.
    Hawryluk, Natalie A.
    Herman, Krystal
    Jones, William M.
    Keith, John M.
    Kim, Suzie
    Koudriakova, Tatiana
    Krawczuk, Paul J.
    Lebsack, Alec D.
    Liu, Jing
    Luna-Roman, Rosa
    Mani, Neelakandha S.
    McClure, Kelly J.
    McGovern, Patricia M.
    Rao, Navin L.
    Rizzolio, Michele C.
    Rosen, Mark D.
    Scott, Brian P.
    Sepassi, Kia
    Skaptason, Judith
    Tootoonchi, Mandana
    Xue, Xiaohua
    Zhu, Jian
    Milla, Marcos E.
    Edwards, James P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [34] Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase
    Araico, A.
    Terencio, M. C.
    Alcaraz, M. J.
    Dominguez, J. N.
    Leon, C.
    Ferrandiz, M. L.
    LIFE SCIENCES, 2006, 78 (25) : 2911 - 2918
  • [35] Synthesis and evaluation of chromone-2-carboxamide derivatives as cytotoxic agents and 5-lipoxygenase inhibitors
    Bousejra-ElGarah, Fatima
    Lajoie, Barbora
    Souchard, Jean-Pierre
    Baziard, Genevieve
    Bouajila, Jalloul
    El Hage, Salome
    MEDICINAL CHEMISTRY RESEARCH, 2016, 25 (11) : 2547 - 2556
  • [36] Synthesis and evaluation of chromone-2-carboxamide derivatives as cytotoxic agents and 5-lipoxygenase inhibitors
    Fatima Bousejra-ElGarah
    Barbora Lajoie
    Jean-Pierre Souchard
    Geneviève Baziard
    Jalloul Bouajila
    Salomé El Hage
    Medicinal Chemistry Research, 2016, 25 : 2547 - 2556
  • [37] BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly
    Garscha, Ulrike
    Voelker, Susanna
    Pace, Simona
    Gerstmeier, Jana
    Emini, Besa
    Liening, Stefanie
    Rossi, Antonietta
    Weinigel, Christina
    Rummler, Silke
    Schubert, Ulrich S.
    Scriba, Gerhard K. E.
    Celikoglu, Ersan
    Caliskan, Burcu
    Banoglu, Erden
    Sautebin, Lidia
    Werz, Oliver
    BIOCHEMICAL PHARMACOLOGY, 2016, 119 : 17 - 26
  • [38] Discovery of Novel 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors by Exploiting a Multistep Virtual Screening Protocol
    Olgac, Abdurrahman
    Carotti, Andrea
    Kretzer, Christian
    Zergiebel, Stephanie
    Seeling, Andreas
    Garscha, Ulrike
    Werz, Oliver
    Macchiarulo, Antonio
    Banoglu, Erden
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (03) : 1737 - 1748
  • [39] Synthesis and Biological Evaluation of N-Aryl-5-aryloxazol-2-amine Derivatives as 5-Lipoxygenase Inhibitors
    Suh, Jee Hee
    Yum, Eul Kgun
    Cho, Young Sik
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2015, 63 (08) : 573 - 578
  • [40] Association of 5-lipoxygenase activating protein gene polymorphism and stroke: A study from north east of Iran
    Erfani, Marjan
    Sadr-Nabavi, Ariane
    Jafarzadeh-Esfehani, Reza
    Shariati, Mohammad
    Ghanbari-Garekani, Leila
    Vojdani-Chahchaheh, Samaneh
    Sasannejad, Payam
    IRANIAN JOURNAL OF NEUROLOGY, 2019, 18 (03) : 114 - 118